| Attribute |
Value |
| 52 Week Change |
0.12631893 |
| Address1 |
6,555 State Highway 161 |
| All Time High |
999.0 |
| All Time Low |
15.0625 |
| Ask |
817.61 |
| Ask Size |
40 |
| Audit Risk |
9 |
| Average Analyst Rating |
1.5 - Strong Buy |
| Average Daily Volume10 Day |
1,200,040 |
| Average Daily Volume3 Month |
1,163,185 |
| Average Volume |
1,163,185 |
| Average Volume10Days |
1,200,040 |
| Beta |
0.315 |
| Bid |
805.0 |
| Bid Size |
40 |
| Board Risk |
6 |
| Book Value |
-18.1 |
| City |
Irving |
| Compensation As Of Epoch Date |
1,798,675,200 |
| Compensation Risk |
1 |
| Country |
United States |
| Crypto Tradeable |
0 |
| Currency |
USD |
| Current Price |
812.28 |
| Current Ratio |
0.854 |
| Custom Price Alert Confidence |
HIGH |
| Date Short Interest |
1,782,777,600 |
| Day High |
822.38 |
| Day Low |
806.24 |
| Display Name |
McKesson |
| Dividend Date |
1,782,864,000 |
| Dividend Rate |
3.28 |
| Dividend Yield |
0.41 |
| Earnings Call Timestamp End |
1,785,960,000 |
| Earnings Call Timestamp Start |
1,785,960,000 |
| Earnings Growth |
0.372 |
| Earnings Quarterly Growth |
0.335 |
| Earnings Timestamp |
1,785,960,000 |
| Earnings Timestamp End |
1,785,960,000 |
| Earnings Timestamp Start |
1,785,960,000 |
| Ebitda |
6,883,999,744 |
| Ebitda Margins |
0.01706 |
| Enterprise To Ebitda |
15.077 |
| Enterprise To Revenue |
0.257 |
| Enterprise Value |
103,788,347,392 |
| Eps Current Year |
44.25177 |
| Eps Forward |
50.33429 |
| Eps Trailing Twelve Months |
38.36 |
| Esg Populated |
0 |
| Ex Dividend Date |
1,780,272,000 |
| Exchange |
NYQ |
| Exchange Data Delayed By |
0 |
| Exchange Timezone Name |
America/New_York |
| Exchange Timezone Short Name |
EDT |
| Fifty Day Average |
769.1304 |
| Fifty Day Average Change |
43.14966 |
| Fifty Day Average Change Percent |
0.056101877 |
| Fifty Two Week Change Percent |
12.631893 |
| Fifty Two Week High |
999.0 |
| Fifty Two Week High Change |
-186.71997 |
| Fifty Two Week High Change Percent |
-0.18690687 |
| Fifty Two Week Low |
637.0 |
| Fifty Two Week Low Change |
175.28003 |
| Fifty Two Week Low Change Percent |
0.27516487 |
| Fifty Two Week Range |
637.0 - 999.0 |
| Financial Currency |
USD |
| First Trade Date Milliseconds |
784,477,800,000 |
| Five Year Avg Dividend Yield |
0.52 |
| Float Shares |
120,015,331 |
| Forward Eps |
50.33429 |
| Forward P E |
16.137707 |
| Free Cashflow |
5,657,625,088 |
| Full Exchange Name |
NYSE |
| Full Time Employees |
41,600 |
| Gmt Off Set Milliseconds |
-14,400,000 |
| Governance Epoch Date |
1,782,864,000 |
| Gross Margins |
0.03601 |
| Gross Profits |
14,526,999,552 |
| Has Pre Post Market Data |
1 |
| Held Percent Insiders |
0.00051 |
| Held Percent Institutions |
0.9594 |
| Implied Shares Outstanding |
117,077,745 |
| Industry |
Medical Distribution |
| Industry Disp |
Medical Distribution |
| Industry Key |
medical-distribution |
| Ir Website |
http://www.mckesson.com/investors/stock-information/stock-information/ |
| Is Earnings Date Estimate |
0 |
| Language |
en-US |
| Last Dividend Date |
1,780,272,000 |
| Last Dividend Value |
0.82 |
| Last Fiscal Year End |
1,774,915,200 |
| Last Split Date |
883,958,400 |
| Last Split Factor |
2:1 |
| Long Business Summary |
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: North American Pharmaceutical, Oncology & Multispecialty, Prescription Technology Solutions, and Medical-Surgical Solutions. The company distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products; delivers products to retail pharmacies, hospitals, long-term care centers, clinics, and institutions; and provides logistics and distribution services for manufacturers. It also provides consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies; gene therapy with InspiroGene, practice consulting, and vaccine distribution services; and technology solutions, as well as research, insights, technologies, and services to improve cancer and specialty care. In addition, the company helps in solving medication access, affordability, and adherence challenges for patients by working across healthcare to connect patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies. Further, it offers technology services, which includes electronic prior authorization, prescription price transparency, benefit insight, dispensing support services, patient enrollment, third-party logistics, and wholesale distribution support; medical-surgical supplies, laboratory equipment, pharmaceutical distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, and hospital reference labs, nursing homes, hospice and home health care agencies, government facilities ,and online marketplaces and retailers. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas. |
| Long Name |
McKesson Corporation |
| Market |
us_market |
| Market Cap |
95,099,912,192 |
| Market State |
POSTPOST |
| Max Age |
86,400 |
| Message Board Id |
finmb_288195 |
| Most Recent Quarter |
1,774,915,200 |
| Net Income To Common |
4,761,999,872 |
| Next Fiscal Year End |
1,806,451,200 |
| Non Diluted Market Cap |
94,359,979,360 |
| Number Of Analyst Opinions |
15 |
| Open |
812.87 |
| Operating Cashflow |
6,154,999,808 |
| Operating Margins |
0.022090001 |
| Overall Risk |
4 |
| Payout Ratio |
0.082600005 |
| Peg Ratio |
1.57 |
| Phone |
972 446 4800 |
| Post Market Change |
3.1479492 |
| Post Market Change Percent |
0.3875448 |
| Post Market Price |
815.428 |
| Post Market Time |
1,783,987,200 |
| Previous Close |
805.96 |
| Price Eps Current Year |
18.355877 |
| Price Hint |
2 |
| Price To Book |
-44.87735 |
| Price To Sales Trailing12 Months |
0.2357284 |
| Profit Margins |
0.0117999995 |
| Quick Ratio |
0.477 |
| Quote Source Name |
Delayed Quote |
| Quote Type |
EQUITY |
| Recommendation Key |
strong_buy |
| Recommendation Mean |
1.47059 |
| Region |
US |
| Regular Market Change |
6.32001 |
| Regular Market Change Percent |
0.784159 |
| Regular Market Day High |
822.38 |
| Regular Market Day Low |
806.24 |
| Regular Market Day Range |
806.24 - 822.38 |
| Regular Market Open |
812.87 |
| Regular Market Previous Close |
805.96 |
| Regular Market Price |
812.28 |
| Regular Market Time |
1,783,972,802 |
| Regular Market Volume |
499,668 |
| Return On Assets |
0.04992 |
| Revenue Growth |
0.06 |
| Revenue Per Share |
3,263.997 |
| Sand P52 Week Change |
0.20847368 |
| Sector |
Healthcare |
| Sector Disp |
Healthcare |
| Sector Key |
healthcare |
| Share Holder Rights Risk |
4 |
| Shares Outstanding |
117,077,745 |
| Shares Percent Shares Out |
0.0352 |
| Shares Short |
4,117,777 |
| Shares Short Previous Month Date |
1,780,012,800 |
| Shares Short Prior Month |
5,237,307 |
| Short Name |
McKesson Corporation |
| Short Percent Of Float |
0.0352 |
| Short Ratio |
3.68 |
| Source Interval |
15 |
| State |
TX |
| Symbol |
MCK |
| Target High Price |
1,065.0 |
| Target Low Price |
812.0 |
| Target Mean Price |
942.06665 |
| Target Median Price |
941.0 |
| Total Cash |
3,975,000,064 |
| Total Cash Per Share |
33.069 |
| Total Debt |
8,785,999,872 |
| Total Revenue |
403,430,014,976 |
| Tradeable |
0 |
| Trailing Annual Dividend Rate |
3.17 |
| Trailing Annual Dividend Yield |
0.003933198 |
| Trailing Eps |
38.36 |
| Trailing P E |
21.175182 |
| Trailing Peg Ratio |
1.5738 |
| Triggerable |
1 |
| Two Hundred Day Average |
829.62067 |
| Two Hundred Day Average Change |
-17.340637 |
| Two Hundred Day Average Change Percent |
-0.020901887 |
| Type Disp |
Equity |
| Volume |
499,668 |
| Website |
https://www.mckesson.com |
| Zip |
75,039 |